Skip to main content

PRQR · ProQR Therapeutics N.V.

Track PRQR — free
$2.07 -0.02 (-0.96%) At close · Sep 4
Market Cap
$292.12M
Shares
141.12M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
15.91M -15.9%
FY2025 Revenue FY2021–FY2025
Net Income
-42.18M -51.9%
FY2025 Net Income FY2015–FY2025
Operating Margin
-273.14% -112pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-52.79M -45.1%
FY2025 Operating Cash Flow FY2015–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015
EUR 15.91M 18.91M 6.51M 3.59M 1.34M
EUR 44.73M 36.36M 25.15M 50.87M 42.22M 38.14M 46.49M 29.51M 31.15M 31.92M 23.4M
EUR 15.06M 13.66M 16.24M 18.65M 17.37M 13.69M 12.89M 12.54M 10.84M 9.48M 6.84M
EUR 2.7M 2.76M 2.51M 2.52M 2.33M 2.36M 2.05M 992K
EUR -43.45M -30.47M -31.86M -65.16M -57.21M -42.37M -57.45M -36.29M -40.5M -39.57M -27M
EUR 1.29M 1.08M 1.46M 5.13M 3.41M 4.03M 1.08M
EUR -42.17M -27.96M -27.81M -64.11M -60.68M -46.49M -56.61M -37.09M -43.67M -39.1M -20.83M
EUR -42.18M -27.76M -28.12M -64.42M -60.74M -46.57M -56.48M -36.89M -43.64M -39.1M -20.83M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.

Key facts CIK 1612940 CUSIP N71542109 13F (30d) 48 filings 48 filers Visit website Investor relations